HIGHLIGHTS
- who: Nadja Chevalier and colleagues from the Department of Physiology, University of Lausanne, Lausanne, Switzerland, Paediatric Oncology have published the research: Assessment of the Chemosensitizing Activity of TAT-RasGAP317-326 in Childhood Cancers, in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0120487]. March 31, 2015 of January/23,/2015
- what: The authors assessed the effect of TAT-RasGAP317-326 in several childhood cancer cell lines. The authors have therefore investigated whether TAT-RasGAP317-326 was able to render childhood tumors more sensitive to clinically relevant anti-tumor drugs. In this study, three types . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.